At 3 years, patients on hemodialysis who developed gout had a 6% lower likelihood of being wait-listed for a kidney transplant. Patients with gout had a 43% higher likelihood of death. BOSTON ...

Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...